{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:23:10Z","timestamp":1783466590436,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48323-7","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:46:16Z","timestamp":1778165176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of SARS-CoV-2 exposure through T cell activation profiles"],"prefix":"10.1038","volume":"16","author":[{"given":"Genevieve C.","family":"Van de Bittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Paredes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Steinfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin B.","family":"Bernick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Kroeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"48323_CR1","unstructured":"Organization, W. H. COVID-19 cases dashboard., <https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c>"},{"key":"48323_CR2","unstructured":"Administration., U. S. F. a. D. Coronavirus Disease 2019 (COVID-19): Public Health Preparedness and Response., <https:\/\/www.fda.gov\/emergency-preparedness-and-response\/public-health-preparedness-and-response\/coronavirus-disease-2019-covid-19>"},{"key":"48323_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41590-022-01184-4","volume":"23","author":"AA Minervina","year":"2022","unstructured":"Minervina, A. A. et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8(+) T cells. Nat. Immunol. 23, 781\u2013790. https:\/\/doi.org\/10.1038\/s41590-022-01184-4 (2022).","journal-title":"Nat. Immunol."},{"key":"48323_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1084\/jem.20030171","volume":"198","author":"S Suvas","year":"2003","unstructured":"Suvas, S., Kumaraguru, U., Pack, C. D., Lee, S. & Rouse, B. T. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 198, 889\u2013901. https:\/\/doi.org\/10.1084\/jem.20030171 (2003).","journal-title":"J. Exp. Med."},{"key":"48323_CR5","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.4049\/jimmunol.175.3.1665","volume":"175","author":"J Hendriks","year":"2005","unstructured":"Hendriks, J. et al. During viral infection of the respiratory tract, CD27, 4\u20131BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 175, 1665\u20131676. https:\/\/doi.org\/10.4049\/jimmunol.175.3.1665 (2005).","journal-title":"J. Immunol."},{"key":"48323_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","author":"JM Dan","year":"2021","unstructured":"Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science https:\/\/doi.org\/10.1126\/science.abf4063 (2021).","journal-title":"Science"},{"key":"48323_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21444-5","volume":"12","author":"AK Wheatley","year":"2021","unstructured":"Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 12, 1162. https:\/\/doi.org\/10.1038\/s41467-021-21444-5 (2021).","journal-title":"Nat. Commun."},{"key":"48323_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24377-1","volume":"12","author":"JH Jung","year":"2021","unstructured":"Jung, J. H. et al. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat. Commun. 12, 4043. https:\/\/doi.org\/10.1038\/s41467-021-24377-1 (2021).","journal-title":"Nat. Commun."},{"key":"48323_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","volume":"28","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant. Nat. Med. 28, 472\u2013476. https:\/\/doi.org\/10.1038\/s41591-022-01700-x (2022).","journal-title":"Nat. Med."},{"key":"48323_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.10871","volume":"5","author":"L De Marco","year":"2022","unstructured":"De Marco, L. et al. Assessment of T-cell reactivity to the SARS-CoV-2 Omicron variant by immunized individuals. JAMA Netw. Open 5, e2210871. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.10871 (2022).","journal-title":"JAMA Netw. Open"},{"key":"48323_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/imcb.12636","volume":"101","author":"C Poloni","year":"2023","unstructured":"Poloni, C. et al. T-cell activation\u2013induced marker assays in health and disease. Immunol. Cell Biol. 101, 491\u2013503. https:\/\/doi.org\/10.1111\/imcb.12636 (2023).","journal-title":"Immunol. Cell Biol."},{"key":"48323_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015 (2020).","journal-title":"Cell"},{"key":"48323_CR13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345. https:\/\/doi.org\/10.1038\/s41590-020-0782-6 (2020).","journal-title":"Nat. Immunol."},{"key":"48323_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34655-1","volume":"13","author":"H Ogura","year":"2022","unstructured":"Ogura, H. et al. Dysfunctional SARS-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. Nat. Commun. 13, 7063. https:\/\/doi.org\/10.1038\/s41467-022-34655-1 (2022).","journal-title":"Nat. Commun."},{"key":"48323_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T Cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168. https:\/\/doi.org\/10.1016\/j.cell.2020.08.017 (2020).","journal-title":"Cell"},{"key":"48323_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17292-4","volume":"11","author":"S De Biasi","year":"2020","unstructured":"De Biasi, S. et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 11, 3434. https:\/\/doi.org\/10.1038\/s41467-020-17292-4 (2020).","journal-title":"Nat. Commun."},{"key":"48323_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4049\/jimmunol.1600318","volume":"197","author":"JM Dan","year":"2016","unstructured":"Dan, J. M. et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T cells in blood. J. Immunol. 197, 983\u2013993. https:\/\/doi.org\/10.4049\/jimmunol.1600318 (2016).","journal-title":"J. Immunol."},{"key":"48323_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186998","volume":"12","author":"S Reiss","year":"2017","unstructured":"Reiss, S. et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS One 12, e0186998. https:\/\/doi.org\/10.1371\/journal.pone.0186998 (2017).","journal-title":"PLoS One"},{"key":"48323_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030050","author":"G Bowyer","year":"2018","unstructured":"Bowyer, G. et al. Activation-induced markers detect vaccine-specific CD4(+) T Cell responses not measured by assays conventionally used in clinical trials. Vaccines https:\/\/doi.org\/10.3390\/vaccines6030050 (2018).","journal-title":"Vaccines"},{"key":"48323_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1099\/vir.0.048652-0","volume":"94","author":"MLB Hillaire","year":"2013","unstructured":"Hillaire, M. L. B. et al. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses. J. Gen. Virol. 94, 583\u2013592. https:\/\/doi.org\/10.1099\/vir.0.048652-0 (2013).","journal-title":"J. Gen. Virol."},{"key":"48323_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12614","volume":"7","author":"H Uchtenhagen","year":"2016","unstructured":"Uchtenhagen, H. et al. Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining. Nat. Commun. 7, 12614. https:\/\/doi.org\/10.1038\/ncomms12614 (2016).","journal-title":"Nat. Commun."},{"key":"48323_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jim.2018.09.004","volume":"463","author":"L Holthaus","year":"2018","unstructured":"Holthaus, L. et al. CD4(+) T cell activation, function, and metabolism are inhibited by low concentrations of DMSO. J. Immunol. Methods. 463, 54\u201360. https:\/\/doi.org\/10.1016\/j.jim.2018.09.004 (2018).","journal-title":"J. Immunol. Methods."},{"key":"48323_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103610","volume":"72","author":"I Quiros-Fernandez","year":"2021","unstructured":"Quiros-Fernandez, I., Poorebrahim, M., Fakhr, E. & Cid-Arregui, A. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naive CD8 T cells of unexposed individuals. EBioMedicine 72, 103610. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103610 (2021).","journal-title":"EBioMedicine"},{"key":"48323_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science https:\/\/doi.org\/10.1126\/science.abd4570 (2020).","journal-title":"Science"},{"key":"48323_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127470","volume":"14","author":"R Tippalagama","year":"2023","unstructured":"Tippalagama, R. et al. Antigen-specificity measurements are the key to understanding T cell responses. Front. Immunol. 14, 1127470. https:\/\/doi.org\/10.3389\/fimmu.2023.1127470 (2023).","journal-title":"Front. Immunol."},{"key":"48323_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.tube.2012.03.008","volume":"92","author":"DC Hsu","year":"2012","unstructured":"Hsu, D. C. et al. A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays. Tuberculosis (Edinb) 92, 321\u2013327. https:\/\/doi.org\/10.1016\/j.tube.2012.03.008 (2012).","journal-title":"Tuberculosis (Edinb)"},{"key":"48323_CR27","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1016\/j.vaccine.2016.09.009","volume":"34","author":"CML Munier","year":"2016","unstructured":"Munier, C. M. L. et al. The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype. Vaccine 34, 5251\u20135261. https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.009 (2016).","journal-title":"Vaccine"},{"key":"48323_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00132-21","author":"B Schouest","year":"2021","unstructured":"Schouest, B. et al. Pre-existing T Cell memory against Zika Virus. J. Virol. https:\/\/doi.org\/10.1128\/JVI.00132-21 (2021).","journal-title":"J. Virol."},{"key":"48323_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2020.102017","volume":"126","author":"S Ubolyam","year":"2021","unstructured":"Ubolyam, S. et al. Performance of a simple flow cytometric assay in diagnosing active tuberculosis. Tuberculosis 126, 102017. https:\/\/doi.org\/10.1016\/j.tube.2020.102017 (2021).","journal-title":"Tuberculosis"},{"key":"48323_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020710","author":"NI Tarbiah","year":"2023","unstructured":"Tarbiah, N. I. et al. T Cells immunophenotyping and CD38 overexpression as hallmarks of the severity of COVID-19 and predictors of patients\u2019 outcomes. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm12020710 (2023).","journal-title":"J. Clin. Med."},{"key":"48323_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100690","volume":"4","author":"A Lemieux","year":"2024","unstructured":"Lemieux, A. et al. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay. Cell Rep. Methods 4, 100690. https:\/\/doi.org\/10.1016\/j.crmeth.2023.100690 (2024).","journal-title":"Cell Rep. Methods"},{"key":"48323_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/1179547617724776","volume":"10","author":"K Pennington","year":"2017","unstructured":"Pennington, K. et al. Flow cytometric immune profiling in Infliximab-associated tuberculosis. Clin. Med. Insights Case Rep. 10, 1179547617724776. https:\/\/doi.org\/10.1177\/1179547617724776 (2017).","journal-title":"Clin. Med. Insights Case Rep."},{"key":"48323_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/AID.2018.0235","volume":"35","author":"WJ Hey-Nguyen","year":"2019","unstructured":"Hey-Nguyen, W. J. et al. HIV-1 DNA is maintained in antigen-specific CD4+ T cell subsets in patients on long-term antiretroviral therapy regardless of recurrent antigen exposure. AIDS Res. Hum. Retroviruses 35, 112\u2013120. https:\/\/doi.org\/10.1089\/AID.2018.0235 (2019).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"48323_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.4049\/jimmunol.1401686","volume":"194","author":"R Das","year":"2015","unstructured":"Das, R. et al. Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo. J. Immunol. 194, 950\u2013959. https:\/\/doi.org\/10.4049\/jimmunol.1401686 (2015).","journal-title":"J. Immunol."},{"key":"48323_CR35","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.3389\/fimmu.2018.03109","volume":"9","author":"AER Kartikasari","year":"2018","unstructured":"Kartikasari, A. E. R. et al. Therapeutic cancer vaccines-T cell responses and epigenetic modulation. Front. Immunol. 9, 3109. https:\/\/doi.org\/10.3389\/fimmu.2018.03109 (2018).","journal-title":"Front. Immunol."},{"key":"48323_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.623475","volume":"8","author":"KP Lim","year":"2021","unstructured":"Lim, K. P. & Zainal, N. S. Monitoring T cells responses mounted by therapeutic cancer vaccines. Front. Mol. Biosci. 8, 623475. https:\/\/doi.org\/10.3389\/fmolb.2021.623475 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"48323_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.878377","volume":"12","author":"R Hernandez","year":"2022","unstructured":"Hernandez, R. & Malek, T. R. Fueling cancer vaccines to improve T cell-mediated antitumor immunity. Front. Oncol. 12, 878377. https:\/\/doi.org\/10.3389\/fonc.2022.878377 (2022).","journal-title":"Front. Oncol."},{"key":"48323_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cpt.2022.12.002","volume":"1","author":"H Ahmed","year":"2023","unstructured":"Ahmed, H. et al. Role of T cells in cancer immunotherapy: Opportunities and challenges. Cancer Pathog. Ther. 1, 116\u2013126. https:\/\/doi.org\/10.1016\/j.cpt.2022.12.002 (2023).","journal-title":"Cancer Pathog. Ther."},{"key":"48323_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174027","author":"AL Huff","year":"2023","unstructured":"Huff, A. L. et al. CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy. JCI. Insight https:\/\/doi.org\/10.1172\/jci.insight.174027 (2023).","journal-title":"JCI. Insight"},{"key":"48323_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01674-3","volume":"8","author":"T Fan","year":"2023","unstructured":"Fan, T. et al. Therapeutic cancer vaccines: Advancements, challenges, and prospects. Signal Transduct. Target. Ther. 8, 450. https:\/\/doi.org\/10.1038\/s41392-023-01674-3 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"48323_CR41","doi-asserted-by":"publisher","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. Seaborn: Statistical data visualization. J. Open Source Softw. 6, 3021. https:\/\/doi.org\/10.21105\/joss.03021 (2021).","journal-title":"J. Open Source Softw."},{"key":"48323_CR42","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48323-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:57:56Z","timestamp":1783465076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48323-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48323"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48323-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare the following competing interests: This research was supported by Agilent Technologies, Inc. and all authors were employed by Agilent Technologies, Inc. during completion of this work. Agilent Technologies, Inc. has filed a patent application, PCT\/US2024\/011684, that covers elements of activation-induced marker assays. G.C.V.d.B., T.P.S., and I.S. are the named inventors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21063"}}